Medobactamsuda Generic Name Pibedil Extended-Release Tablets and Silegilan Tablets Generic Name Silegilan Hydrochloride Tablets can be taken at the same time. When used alone, selegiline hydrochloride tablets can be used to treat early Parkinson’s disease or in combination with levodopa or with levodopa and peripheral dopa decarboxylase inhibitors. Common adverse reactions to taking this product are symptoms such as nausea, confusion, hallucinations, and headache. In addition, it is contraindicated for those who are allergic to any of the ingredients in this product, those with peptic ulcers, and those with severe psychosis and dementia, and it is contraindicated for concurrent use with pethidine. In addition, it should be used with caution in pregnant women and infants. Piribedil extended-release tablets is a long-acting anti-Parkinson’s disease drug, mainly used in elderly patients with chronic pathological cognitive and sensory neurological deficits in the adjunctive symptomatic treatment. It is also used as adjunctive treatment for intermittent claudication due to chronic obstructive arterial disease of the lower extremities in the second stage. Common adverse reactions to the administration of this product include gastrointestinal reactions such as nausea, vomiting, flatulence, and occasional reactions such as lethargy may be seen. It should be noted that hypersensitivity to any of the components of the product, as well as patients in the acute stage of cardiovascular shock or myocardial infarction is contraindicated. You need to consult a doctor before using the drug, follow the doctor’s instructions, and do not use it arbitrarily on your own.